List of works - Núria Climent

A gene (wbbL) from Serratia marcescens N28b (O4) complements the rfb-50 mutation of Escherichia coli K-12 derivatives.

scientific article published on December 1997

A therapeutic dendritic cell-based vaccine for HIV-1 infection

scientific article published on 13 January 2011

Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV.

scientific article published on 11 August 2009

Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals

scientific article

Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells.

scientific article published on 19 October 2010

Adenosine deaminase regulates Treg expression in autologous T cell-dendritic cell cocultures from patients infected with HIV-1.

scientific article published on 26 August 2015

An old enzyme for current needs: adenosine deaminase and a dendritic cell vaccine for HIV.

scientific article

Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients

scientific article published in May 2009

CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.

scientific article

Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells

scientific article

Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.

scientific article published on December 2014

Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands

scientific article published on 2 November 2015

Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.

scientific article

Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines

article

Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells

scientific article published on 01 July 2007

Genetic characterization of the Klebsiella pneumoniae waa gene cluster, involved in core lipopolysaccharide biosynthesis

scientific article

HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection

scientific article published on 01 November 2007

Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses

scientific article

Human immature monocyte-derived dendritic cells produce and secrete α-defensins 1-3

scientific article published on 07 August 2007

Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.

scientific article published in November 2009

Impact of alpha-defensins1-3 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects.

scientific article published on 23 February 2009

Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients.

scientific article published on 05 June 2017

Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression

scientific article

Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation.

scientific article published on 18 March 2016

Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.

scientific article published on 19 September 2014

P10-13. Increased production of alpha-defensins 1–3 by dendritic cells in HIV-infected individuals is associated with a slower disease progression rate.

scientific article published on 22 October 2009

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02).

scientific article published on 22 October 2009

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1

article

Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS

scientific article published on 9 June 2010

Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion

scientific article published on 24 August 2006

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection

article

List of works by Núria Climent

A gene (wbbL) from Serratia marcescens N28b (O4) complements the rfb-50 mutation of Escherichia coli K-12 derivatives.

A therapeutic dendritic cell-based vaccine for HIV-1 infection

Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV.

Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals

Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells.

Adenosine deaminase regulates Treg expression in autologous T cell-dendritic cell cocultures from patients infected with HIV-1.

An old enzyme for current needs: adenosine deaminase and a dendritic cell vaccine for HIV.

Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients

CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.

Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells

Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.

Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands

Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.

Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines

Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells

Genetic characterization of the Klebsiella pneumoniae waa gene cluster, involved in core lipopolysaccharide biosynthesis

HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection

Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses

Human immature monocyte-derived dendritic cells produce and secrete α-defensins 1-3

Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.

Impact of alpha-defensins1-3 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects.

Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients.

Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression

Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation.

Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.

P10-13. Increased production of alpha-defensins 1–3 by dendritic cells in HIV-infected individuals is associated with a slower disease progression rate.

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02).

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1

Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS

Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection